In ESCC, it was discovered that IL-6 regulated the immunosuppressive tumor microenvironment, partially explaining the poor reaction of immunotherapy in patients with elevated IL-6 levels. The gene discussed is IL6; the disease is esophageal squamous cell carcinoma.